Curis
CRIS
#11032
Rank
โ‚ฌ5.42 M
Marketcap
0,81ย โ‚ฌ
Share price
6.65%
Change (1 day)
-28.40%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2023 (TTM): -9,51ย โ‚ฌ

According to Curis's latest financial reports the company's current EPS (TTM) is -12,73ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -10,92ย โ‚ฌ a decrease over its 2021 EPS that were of -8,95ย โ‚ฌ.

EPS history for Curis from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-9,51ย โ‚ฌ-12.96%
2022-10,92ย โ‚ฌ22%
2021-8,95ย โ‚ฌ-25.37%
2020-12,00ย โ‚ฌ-30.93%
2019-17,37ย โ‚ฌ-2.02%
2018-17,73ย โ‚ฌ-37.38%
2017-28,31ย โ‚ฌ-29.73%
2016-40,29ย โ‚ฌ-10%
2015-44,76ย โ‚ฌ138.1%
2014-18,80ย โ‚ฌ40%
2013-13,43ย โ‚ฌ-25%
2012-17,91ย โ‚ฌ66.67%
2011-10,74ย โ‚ฌ-850%
20101,43ย โ‚ฌ-114.29%
2009-10,03ย โ‚ฌ-26.07%
2008-13,56ย โ‚ฌ-26.28%
2007-18,40ย โ‚ฌ8.44%
2006-16,97ย โ‚ฌ-32.68%
2005-25,20ย โ‚ฌ-3.76%
2004-26,19ย โ‚ฌ62.95%
2003-16,07ย โ‚ฌ-93.86%
2002-261,65ย โ‚ฌ39.5%
2001-187,57ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,68ย โ‚ฌ-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,05ย โ‚ฌ-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,32ย โ‚ฌ-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
3,10ย โ‚ฌ-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,89ย โ‚ฌ-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-2,85ย โ‚ฌ-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-3,08ย โ‚ฌ-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA